Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.36
(
-1.28%
)
Bitcoin
74,375.88
(
0.59%
)
News Focus
News Focus

Replies to post #128962 on Biotech Values

Replies to #128962 on Biotech Values
icon url

oc631

10/21/11 1:03 PM

#128965 RE: DewDiligence #128962

ABT-267 (the NS5A inhibitor) may enable ribavirin to be ditched from ABT’s all-oral cocktail.




Big deal. What about treatment duration?